Pharmaceutical and biotechnology organizations rely on advanced drug discovery screening platforms to identify promising therapeutic candidates with greater speed and biological relevance. The global High Content Screening Market was valued at USD 1.57 billion in 2025 and is projected to expand from USD 1.68 billion in 2026 to USD 2.93 billion by 2034, registering a compound...
English
Indonesia
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek